Bio-Medical Applications Of Pennsylvania, Inc. in Philadelphia, Pennsylvania - Dialysis Center

Bio-Medical Applications Of Pennsylvania, Inc. is a medicare approved dialysis facility center in Philadelphia, Pennsylvania and it has 11 dialysis stations. It is located in Philadelphia county at 5201 Old York Road, Philadelphia, PA, 19141. You can reach out to the office of Bio-Medical Applications Of Pennsylvania, Inc. at (215) 457-2261. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Pennsylvania, Inc. has the following ownership type - Profit. It was first certified by medicare in November, 2015. The medicare id for this facility is 392835 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameBio-Medical Applications Of Pennsylvania, Inc.
Location5201 Old York Road, Philadelphia, Pennsylvania
No. of Dialysis Stations 11
Medicare ID392835
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


5201 Old York Road, Philadelphia, Pennsylvania, 19141
(215) 457-2261

Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of Pennsylvania, Inc. from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1063806123
Organization NameFresenius Medical Care Logan
Doing Business AsBio-medical Applications Of Pennsylvania, Inc.
Address5201 Old York Rd Philadelphia, Pennsylvania, 19141
Phone Number(215) 457-4159

NPI Number1477657245
Organization NameBma Cambria
Doing Business AsBio-medical Applications Of Pennsylvania, Inc.
Address2850 N 21st St Philadelphia, Pennsylvania, 19132
Phone Number(215) 227-6883

NPI Number1700233020
Organization NameFresenius Kidney Care Fox Chase
Doing Business AsBio-medical Applications Of Pennsylvania, Inc.
Address700 Cottman Ave Philadelphia, Pennsylvania, 19111
Phone Number(215) 745-0414

NPI Number1710081583
Organization NameBma St. Agnes
Doing Business AsBio-medical Applications Of Pennsylvania, Inc.
Address1900 S Broad St Philadelphia, Pennsylvania, 19145
Phone Number(215) 339-4482

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data19
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL21

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center50
    Adult patient months included in Kt/V greater than or equal to 1.2344
    Percentage of adult patients getting regular hemodialysis at the center97
    Percentage of pediatric patients getting regular hemodialysis at the center

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of Pennsylvania, Inc. with elevated calcium levels.

Patients with hypercalcemia51
Hypercalcemia patient months348
Hypercalcemia patients with serumcalcium greater than 10.2 mg2
Patients with Serumphosphor53
Patients with Serumphosphor less than 3.5 mg/dL12
Patients with Serumphosphor from 3.5 to 4.5 mg/dL31
Patients with Serumphosphor from 4.6 to 5.5 mg/dL30
Patients with Serumphosphor from 5.6 to 7 mg/dL23
Patients with Serumphosphor greater than 7 mg/dL4

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 32
Patient months included in arterial venous fistula and catheter summaries 211
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment63
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer18

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary17
Hospitalization Rate in facility247.3 (As Expected)
Hospitalization Rate: Upper Confidence Limit695.4
Hospitalization Rate: Lower Confidence Limit95.4

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Bio-Medical Applications Of Pennsylvania, Inc. were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility21.5 (As Expected)
Readmission Rate: Upper Confidence Limit40
Readmission Rate: Lower Confidence Limit8.7